You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fulvestrant

Showing 26 - 50 of 466
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer Trial in Madison, Milwaukee (Onapristone, Fulvestrant)

Recruiting
  • ER-positive Breast Cancer
  • +2 more
  • Madison, Wisconsin
  • +1 more
Jul 7, 2022

ER-Positive Breast Cancer, HER2-negative Breast Cancer Trial in Houston (Fulvestrant Run-In, No Fulvestrant Run-In)

Recruiting
  • ER-Positive Breast Cancer
  • HER2-negative Breast Cancer
  • Fulvestrant Run-In
  • No Fulvestrant Run-In
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 23, 2022

ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

Recruiting
  • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
  • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
  • Montpellier, France
  • +1 more
Nov 16, 2022

Adenocarcinoma of Endometrium Trial in United States (Fulvestrant, Abemaciclib)

Recruiting
  • Adenocarcinoma of Endometrium
  • Basking Ridge, New Jersey
  • +6 more
Oct 12, 2022

HR-positive,HER2-negative in Advanced Breast Cancer Trial in Beijing (TQB3616 capsules, TQB3616-matching , Fluvestrin injection)

Recruiting
  • HR-positive,HER2-negative in Advanced Breast Cancer
  • TQB3616 capsules
  • +2 more
  • Beijing, Beijing, China
  • +1 more
May 11, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 12, 2022

Advanced Breast Cancer Trial in Orebro (Alpelisib, fulvestrant)

Terminated
  • Advanced Breast Cancer
  • Orebro, Sweden
  • +1 more
Nov 21, 2022

Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Dec 5, 2022

Advanced Breast Cancer Trial in Beijing (XZP-3287+Fulvestrant, Placebo + Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Beijing, Beijing, China
    Chinese Academy of Medical Science
Jan 4, 2022

Advanced Solid Tumor, Breast Cancer Trial in Columbus, San Antonio, West Valley City (CFI-402257, Fulvestrant)

Recruiting
  • Advanced Solid Tumor
  • Breast Cancer
  • Columbus, Ohio
  • +2 more
Jul 26, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • (no location specified)
Nov 8, 2022

Breast Cancer, Breast Cancer Female Trial in China (surufatinib + fulvestrant + chidamide)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer Female
  • surufatinib + fulvestrant + chidamide
  • Anyang, China
  • +4 more
Jul 18, 2022

Female Breast Carcinoma, Female Ductal Carcinoma In Situ Trial in Baltimore, New York (Fulvestrant)

Terminated
Has Results
  • Female Breast Carcinoma
  • Female Ductal Carcinoma In Situ
  • Fulvestrant
  • Baltimore, Maryland
  • +1 more
Mar 15, 2022

Ovarian Cancer, Serous Ovarian Cancer Trial in Pittsburgh (Regorafenib, Fulvestrant)

Not yet recruiting
  • Ovarian Cancer
  • Serous Ovarian Cancer
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Apr 17, 2022

Advanced Breast Cancer, Female Breast Cancer Trial in Shanghai (FCN-437c,Fulvestrant,Goserelin acetate,

Recruiting
  • Advanced Breast Cancer
  • Female Breast Cancer
  • FCN-437c,Fulvestrant,Goserelin acetate
  • Placebo,Fulvestrant,Goserelin acetate
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 30, 2022

Breast Cancer Trial in China, United States (Afuresertib)

Recruiting
  • Breast Cancer
  • Santa Monica, California
  • +11 more
Nov 30, 2022

Breast Cancer, Brain Metastases Trial in Guangzhou (Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant)

Recruiting
  • Breast Cancer
  • Brain Metastases
  • Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant
  • Guangzhou, Guangdong, China
  • +1 more
Apr 24, 2022

Breast Cancer Trial in Aurora, New York, Germantown (Enzalutamide, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +2 more
Feb 22, 2022

HER2 Low Advanced or Metastatic Breast Cancer Trial (SHR-A1811 & Dalpiciclib Isethionate Tablets, SHR-A1811 & Fulvestrant,

Not yet recruiting
  • HER2 Low Advanced or Metastatic Breast Cancer
  • SHR-A1811 & Dalpiciclib Isethionate Tablets
  • +2 more
  • (no location specified)
Mar 19, 2023

Breast Tumors Trial in China (Alpelisib, Fulvestrant, Placebo)

Recruiting
  • Breast Neoplasms
  • Hefei, Anhui, China
  • +31 more
Dec 19, 2022

A NIS of Alpelisib in Combination With Fulvestrant in

Not yet recruiting
  • Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
  • Alpelisib
  • Fulvestrant
  • (no location specified)
Aug 9, 2022

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

Advanced Breast Cancer Trial in Changsha (BEBT-209 capsules, Letrozole tablets, Fulvestrant)

Active, not recruiting
  • Advanced Breast Cancer
  • BEBT-209 capsules
  • +2 more
  • Changsha, Hunan, China
  • +1 more
Sep 14, 2023